tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ABBV Stock Latest News

AbbVie’s Atogepant Study: A New Hope for Menstrual Migraine Prevention
Company AnnouncementsAbbVie’s Atogepant Study: A New Hope for Menstrual Migraine Prevention
1d ago
ABBV
AbbVie’s Promising Phase 2 Study on Metastatic Colorectal Cancer
PremiumCompany Announcements
AbbVie’s Promising Phase 2 Study on Metastatic Colorectal Cancer
1d ago
ABBV
AbbVie’s SELECT-SLE Study: A Potential Game Changer for Lupus Treatment
PremiumCompany Announcements
AbbVie’s SELECT-SLE Study: A Potential Game Changer for Lupus Treatment
1d ago
ABBV
AbbVie’s Promising Phase 2 Study on Atopic Dermatitis Treatment
PremiumCompany Announcements
AbbVie’s Promising Phase 2 Study on Atopic Dermatitis Treatment
1d ago
ABBV
AbbVie’s New Study on Ulcerative Colitis: A Potential Game Changer?
PremiumCompany Announcements
AbbVie’s New Study on Ulcerative Colitis: A Potential Game Changer?
1d ago
ABBV
AbbVie’s Ubrogepant Study: A New Hope for Menstrual Migraine Relief
PremiumCompany AnnouncementsAbbVie’s Ubrogepant Study: A New Hope for Menstrual Migraine Relief
1d ago
ABBV
AbbVie’s SWITCH-UP Study: A New Hope for Atopic Dermatitis Patients
Premium
Company Announcements
AbbVie’s SWITCH-UP Study: A New Hope for Atopic Dermatitis Patients
1d ago
ABBV
AbbVie’s Promising Phase 3 Study on Upadacitinib for Hidradenitis Suppurativa
Premium
Company Announcements
AbbVie’s Promising Phase 3 Study on Upadacitinib for Hidradenitis Suppurativa
1d ago
ABBV
AbbVie’s Linaclotide Study: A Potential Breakthrough for Pediatric Constipation
PremiumCompany Announcements
AbbVie’s Linaclotide Study: A Potential Breakthrough for Pediatric Constipation
2d ago
ABBV
AbbVie’s Promising Phase 2 Study on Urothelial Carcinoma Treatment
PremiumCompany Announcements
AbbVie’s Promising Phase 2 Study on Urothelial Carcinoma Treatment
2d ago
ABBV
AbbVie Advances Pediatric Arthritis Treatment with New Study on Upadacitinib
PremiumCompany Announcements
AbbVie Advances Pediatric Arthritis Treatment with New Study on Upadacitinib
2d ago
ABBV
AbbVie’s ABBV-319 Study: A New Hope for B-cell Malignancies
PremiumCompany Announcements
AbbVie’s ABBV-319 Study: A New Hope for B-cell Malignancies
2d ago
ABBV
AbbVie’s Promising Phase 3 Study on Atogepant for Menstrual Migraine Prevention
PremiumCompany AnnouncementsAbbVie’s Promising Phase 3 Study on Atogepant for Menstrual Migraine Prevention
2d ago
ABBV
AbbVie’s Promising Phase 3 Study on Lutikizumab for Hidradenitis Suppurativa
Premium
Company Announcements
AbbVie’s Promising Phase 3 Study on Lutikizumab for Hidradenitis Suppurativa
2d ago
ABBV
AbbVie’s Tavapadon Bioavailability Study Completes: Key Insights for Investors
Premium
Company Announcements
AbbVie’s Tavapadon Bioavailability Study Completes: Key Insights for Investors
2d ago
ABBV
AbbVie’s Study on Mitigating Ocular Toxicity in Ovarian Cancer Treatment
PremiumCompany Announcements
AbbVie’s Study on Mitigating Ocular Toxicity in Ovarian Cancer Treatment
2d ago
ABBV
AbbVie’s ABBV-400 Study: A Potential Game-Changer in Colorectal Cancer Treatment
PremiumCompany Announcements
AbbVie’s ABBV-400 Study: A Potential Game-Changer in Colorectal Cancer Treatment
2d ago
ABBV
AbbVie Advances Real-world Study on OZURDEX for Diabetic Macular Edema in China
PremiumCompany Announcements
AbbVie Advances Real-world Study on OZURDEX for Diabetic Macular Edema in China
2d ago
ABBV
AbbVie’s Promising New Study on Targeted Therapies for Rheumatoid Arthritis
PremiumCompany Announcements
AbbVie’s Promising New Study on Targeted Therapies for Rheumatoid Arthritis
2d ago
ABBV
AbbVie’s Upadacitinib Study: A Potential Game-Changer for SLE Treatment
PremiumCompany AnnouncementsAbbVie’s Upadacitinib Study: A Potential Game-Changer for SLE Treatment
2d ago
ABBV
AbbVie’s Promising Phase 3 Study on Telisotuzumab Vedotin for NSCLC
Premium
Company Announcements
AbbVie’s Promising Phase 3 Study on Telisotuzumab Vedotin for NSCLC
2d ago
ABBV
AbbVie’s Promising Phase 2 Study on Metastatic Colorectal Cancer Treatment
Premium
Company Announcements
AbbVie’s Promising Phase 2 Study on Metastatic Colorectal Cancer Treatment
2d ago
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >